← All trials
NCT06840756
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2025
- Primary completion
- Dec 31, 2028
- Completion date
- Mar 31, 2029
- First posted
- Feb 21, 2025
- Last posted
- Jul 10, 2025
- Enrollment
- 11082
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- McMaster UniversityLead sponsor
- McMaster UniversityOfficial
- McMaster UniversitySponsor investigator
- Canadian Institutes of Health Research (CIHR)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.